|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Number of the document | 2889310 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15155712.1 |
| Date of filing the European patent application | 2008-07-03 | |
| (97) | Date of publication of the European application | 2015-07-01 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-20 |
| (46) | Date of publication of the claims translation | 2018-03-26 |
| (30) | Number | Date | Country code |
| 948220 P | 2007-07-06 | US |
| (72) |
Brisbane, Charlene E, US
Ketkar, Amol Sharad, US
Lashmar, Ulla Tove, GB
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnų kompozicijos |
| Antibody formulations |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 18 | 347.00 EUR |
| 2026-07-03 |